Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

NCT00897312 · clinicaltrials.gov ↗

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Melanoma

Interventions

BIOLOGICAL: infliximab
BIOLOGICAL: pegylated interferon alfa
BIOLOGICAL: ticilimumab
DRUG: ribavirin
OTHER: high performance liquid chromatography
OTHER: laboratory biomarker analysis

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]